References
- Delaloye, J.; Calandra, T. Invasive Candidiasis as a Cause of Sepsis in the Critically Ill Patient. Virulence 2014, 5, 161–162. DOI: https://doi.org/10.4161/viru.26187.
- Chayakulkeeree, M.; Denning, D. W. Serious Fungal Infections in Thailand. Eur. J. Clin. Microbiol. Infect. Dis. 2017, 36, 931–935. DOI: https://doi.org/10.1007/s10096-017-2927-6.
- Netea, M. G.; Joosten, L. A. B.; Van der Meer, J. W. M.; Kullberg, B.-J.; Van de Veerdonk, F. L. Immune Defence against Candida Fungal Infections. Nat. Rev. Immunol. 2015, 15, 630–642. DOI: https://doi.org/10.1038/nri3897.
- Ramos, M. A. S.; Silva, P. B.; Spósito, L.; Toledo, L. G.; Bonifácio, B.; V; Rodero, C. F.; Santos, K. C.; Chorilli, M.; Bauab, T. M. Nanotechnology-Based Drug Delivery Systems for Control of Microbial Biofilms: A Review. Int. J. Nanomed. 2018, 13, 1179–1213. DOI: https://doi.org/10.2147/IJN.S146195.
- Ramos, M. A. S.; Silva, P. B.; Toledo, L. G.; Oda, F. B.; Silva, I. C.; Santos, L. C.; Santos, A. G.; Almeida, M. T. G.; Pavan, F. R.; Chorilli, M.; et al. Intravaginal Delivery of Syngonanthus Nitens (Bong.) Ruhland Fraction Based on a Nanoemulsion System Applied to Vulvovaginal Candidiasis Treatment. J. Biomed. Nanotechnol. 2019, 15, 1072–1089. DOI: https://doi.org/10.1166/jbn.2019.2750.
- McCarty, T. P.; Pappas, P. G. Invasive Candidiasis. Infect. Dis. Clin. North Am. 2016, 30, 103–124. DOI: https://doi.org/10.1016/j.idc.2015.10.013.
- Marena, G. D.; Ramos, M. A. S.; Bauab, T. M.; Chorilli, M. Biological Properties and Analytical Methods for Micafungin: A Critical Review. Crit. Rev. Anal. Chem. 2020, 1–17. https://doi.org/10.1080/10408347.2020.1726726.
- Campoy, S.; Adrio, J. L. Antifungals. Biochem. Pharmacol. 2017, 133, 86–96. DOI: https://doi.org/10.1016/j.bcp.2016.11.019.
- Ramos, M. A. S.; Calixto, G.; Toledo, L. G.; Bonifácio, B. V.; Santos, L. C.; Almeida, M. T. G.; Chorilli, M.; Bauab, T. M. Liquid Crystal Precursor Mucoadhesive System as a Strategy to Improve the Prophylactic Action of Syngonanthus Nitens (Bong.) Ruhland against Infection by Candida Krusei. Int. J. Nanomed. 2015, 10, 7455–7466. DOI: https://doi.org/10.2147/IJN.S92638.
- Ramos, M. A. S.; Toledo, L. G.; Calixto, G. M. F.; Bonifácio, B. V.; Araújo, M. G. F.; Santos, L. C.; Almeida, M. T. G.; Chorilli, M.; Bauab, T. M. Syngonanthus Nitens Bong. (Rhul.)-Loaded Nanostructured System for Vulvovaginal Candidiasis Treatment. Int. J. Mol. Sci. 2016, 17, 1368–1387. DOI: https://doi.org/10.3390/ijms17081368.
- Hamdan, J. S.; Hahn, R. C. Antifungal Drugs for Systemic Mycosis: An Overview of Mechanism of Action and Resistance. Antiinfect. Agents Med. Chem. 2006, 5, 403–412. DOI: https://doi.org/10.2174/187152106778520479.
- Spanakis, E. K.; Aperis, G.; Mylonakis, E. Reviews of Anti‐Infective Agents: New Agents for the Treatment of Fungal Infections: Clinical Efficacy and Gaps in Coverage. Clin. Infect. Dis. 2006, 43, 1060–1068. DOI: https://doi.org/10.1086/507891.
- Laniado-Laborín, R.; Cabrales-Vargas, M. N. Amphotericin B: Side Effects and Toxicity. Rev. Iberoam. Micol. 2009, 26, 223–227. DOI: https://doi.org/10.1016/j.riam.2009.06.003.
- Baginski, M.; Czub, J. Amphotericin B and Its New Derivatives - Mode of Action. Curr. Drug Metab. 2009, 10, 459–469. DOI: https://doi.org/10.2174/138920009788898019.
- Lemke, A.; Kiderlen, A. F.; Kayser, O. Amphotericin B. Appl. Microbiol. Biotechnol. 2005, 68, 151–162. DOI: https://doi.org/10.1007/s00253-005-1955-9.
- Falci, D. R.; Da Rosa, F. B.; Pasqualotto, A. C. Hematological Toxicities Associated with Amphotericin B Formulations. Leuk. Lymphoma. 2015, 56, 2889–2894. DOI: https://doi.org/10.3109/10428194.2015.1010080.
- Serrano, D. R.; Fernandez-Garcia, R.; Mele, M.; Healy, A. M.; Lalatsa, A. Designing Fast-Dissolving Orodispersible Films of Amphotericin b for Oropharyngeal Candidiasis. Pharmaceutics 2019, 11, 369–316. DOI: https://doi.org/10.3390/pharmaceutics11080369.
- Liu, M.; Chen, M.; Yang, Z. Design of Amphotericin B Oral Formulation for Antifungal Therapy. Drug Deliv. 2017, 24, 1–9. DOI: https://doi.org/10.1080/10717544.2016.1225852.
- Vieira, D. B.; Carmona-Ribeiro, A. M. Synthetic Bilayer Fragments for Solubilization of Amphotericin B. J. Colloid Interface Sci. 2001, 244, 427–431. DOI: https://doi.org/10.1006/jcis.2001.7975.
- Ehrenfreund-Kleinman, T.; Azzam, T.; Falk, R.; Polacheck, I.; Golenser, J.; Domb, A. J. Synthesis and Characterization of Novel Water Soluble Amphotericin B-Arabinogalactan Conjugates. Biomaterials 2002, 23, 1327–1335. DOI: https://doi.org/10.1016/S0142-9612(01)00251-4.
- Kleinberg, M. What is the Current and Future Status of Conventional Amphotericin B? Int. J. Antimicrob. Agents 2006, 27, 12–16. DOI: https://doi.org/10.1016/j.ijantimicag.2006.03.013.
- Mesa-Arango, A. C.; Scorzoni, L.; Zaragoza, O. It Only Takes One to Do Many Jobs: Amphotericin B as Antifungal and Immunomodulatory Drug. Front. Microbiol. 2012, 3, 286–210. DOI: https://doi.org/10.3389/fmicb.2012.00286.
- Freires, I. D. A.; Murata, R. M.; Furletti, V. F.; Sartoratto, A.; Alencar, S. M.; de Figueira, G. M.; de Oliveira Rodrigues, J. A.; Duarte, M. C. T.; Rosalen, P. L.; Coriandrum Sativum, L. ( Coriander) Essential Oil: Antifungal Activity and Mode of Action on Candida Spp., and Molecular Targets Affected in Human Whole-Genome Expression. PLoS One. 2014, 9, e99086. DOI: https://doi.org/10.1371/journal.pone.0099086.
- Falcón-González, J. M.; Jiménez-Domínguez, G.; Ortega-Blake, I.; Carrillo-Tripp, M. Multi-Phase Solvation Model for Biological Membranes: Molecular Action Mechanism of Amphotericin B. J. Chem. Theory Comput. 2017, 13, 3388–3397. DOI: https://doi.org/10.1021/acs.jctc.7b00337.
- Kim, J. H.; Faria, N. C. G.; Martins, M. D. L.; Chan, K. L.; Campbell, B. C. Enhancement of Antimycotic Activity of Amphotericin B by Targeting the Oxidative Stress Response of Candida and Cryptococcus with Natural Dihydroxybenzaldehydes. Front. Microbiol. 2012, 3, 261–266. DOI: https://doi.org/10.3389/fmicb.2012.00261.
- Kim, N.; Choi, J. W.; Park, H. R.; Kim, I.; Kim, H. S. Amphotericin B, an Anti-Fungal Medication, Directly Increases the Cytotoxicity of NK Cells. Int. J. Mol. Sci. 2017, 18, 1262. DOI: https://doi.org/10.3390/ijms18061262.
- Batista-Duharte, A.; Lastre, M.; Romeu, B.; Portuondo, D. L.; Téllez-Martínez, D.; Manente, F. A.; Pérez, O.; Carlos, I. Z. Antifungal and Immunomodulatory Activity of a Novel Cochleate for Amphotericin B Delivery against Sporothrix Schenckii. Int. Immunopharmacol. 2016, 40, 277–287. DOI: https://doi.org/10.1016/j.intimp.2016.09.008.
- Eriksson, U.; Seifert, B.; Schaffner, A. Comparison of Effects of Amphotericin B Deoxycholate Infused over 4 or 24 Hours: Randomised Controlled Trial. BMJ 2001, 322, 579–582. DOI: https://doi.org/10.1136/bmj.322.7286.579.
- Deray, G.; Mercadal, L.; Bagnis, C. [Nephrotoxicity of Amphotericin B]. Nephrologie 2002, 23, 119–122. https://doi.org/10.1093/jac/49.suppl_1.37.
- Steimbach, L. M.; Tonin, F. S.; Virtuoso, S.; Borba, H. H. L.; Sanches, A. C. C.; Wiens, A.; Fernandez-Llimós, F.; Pontarolo, R. Efficacy and Safety of Amphotericin B Lipid-Based formulations - A Systematic Review and Meta-Analysis. Mycoses 2017, 60, 146–154. DOI: https://doi.org/10.1111/myc.12585.
- Bes, D. F.; Rosanova, M. T.; Sberna, N.; Arrizurieta, E. Deoxycholate Amphotericin B and Nephrotoxicity in the Pediatric Setting. Pediatr. Infect. Dis. J. 2014, 33, 198–206. https://doi.org/10.1097/INF.0000000000000299.
- Zheng, Y. H.; Ma, Y. Y.; Ding, Y.; Chen, X. Q.; Gao, G. X. An Insight into New Strategies to Combat Antifungal Drug Resistance. Drug Des. Dev. Ther. 2018, 12, 3807–3816. DOI: https://doi.org/10.2147/DDDT.S185833.
- Mueller, Y.; Nguimfack, A.; Cavailler, P.; Couffignal, S.; Rwakimari, J. B.; Loutan, L.; Chappuis, F. Safety and Effectiveness of Amphotericin B Deoxycholate for the Treatment of Visceral Leishmaniasis in Uganda. Ann. Trop. Med. Parasitol. 2008, 102, 11–19. DOI: https://doi.org/10.1179/136485908X252142.
- Hamill, R. J. Amphotericin B Formulations: A Comparative Review of Efficacy and Toxicity. Drugs 2013, 73, 919–934. DOI: https://doi.org/10.1007/s40265-013-0069-4.
- Janknegt, R.; de Marie, S.; Bakker-Woudenberg, I. A. J. M.; Crommelin, D. J. A. Liposomal and Lipid Formulations of Amphotericin B. Clinical pharmacokinetics. Clin. Pharmacokinet. 1992, 23, 279–291. DOI: https://doi.org/10.2165/00003088-199223040-00004.
- Al-Adham, I. S. I.; Ashour, H.; Al-Kaissi, E.; Khalil, E.; Kierans, M.; Collier, P. J. Studies on the Kinetics of Killing and the Proposed Mechanism of Action of Microemulsions against Fungi. Int. J. Pharm. 2013, 454, 226–232. DOI: https://doi.org/10.1016/j.ijpharm.2013.06.049.
- Hiemenz, J. W.; Walsh, T. J. Lipid Formulations of Amphotericin B. J. Liposome Res. 1998, 8, 443–467. DOI: https://doi.org/10.3109/08982109809039931.
- Adler-Moore, J.; Proffitt, R. T. AmBisome: Liposomal Formulation, Structure, Mechanism of Action and Pre-Clinical Experience. J. Antimicrob. Chemother. 2002, 49, 21–30. DOI: https://doi.org/10.1093/jac/49.suppl_1.21.
- Chandrasekar, P. H. Amphotericin B Lipid Complex: Treatment of Invasive Fungal Infections in Patients Refractory to or Intolerant of Amphotericin B Deoxycholate. Ther. Clin. Risk Manag. 2008, 4, 1285–1294. DOI: https://doi.org/10.2147/tcrm.s1554.
- Adedoyin, A.; Bernardo, J. F.; Swenson, C. E.; Bolsack, L. E.; Horwith, G.; DeWit, S.; Kelly, E.; Klasterksy, J.; Sculier, J. P.; DeValeriola, D.; et al. Pharmacokinetic Profile of ABELCET (Amphotericin B Lipid Complex Injection): Combined Experience from Phase I and Phase II Studies. Antimicrob. Agents Chemother. 1997, 41, 2201–2208. DOI: https://doi.org/10.1128/AAC.41.10.2201.
- Guo, L. S. S.; Fielding, R. M.; Lasic, D. D.; Hamilton, R. L.; Mufson, D. Novel Antifungal Drug Delivery: Stable Amphotericin B-Cholesteryl Sulfate Discs. Int. J. Pharm. 1991, 75, 45–54. DOI: https://doi.org/10.1016/0378-5173(91)90249-N.
- Hanson, L. H.; Stevens, D. A. Comparison of Antifungal Activity of Amphotericin B Deoxycholate Suspension with that of Amphotericin B Cholesteryl Sulfate Colloidal Dispersion. Antimicrob. Agents Chemother. 1992, 36, 486–488. DOI: https://doi.org/10.1128/aac.36.2.486.
- Fielding, R. M.; Singer, A. W.; Wang, L. H.; Babbar, S.; Guo, L. S. S. Relationship of Pharmacokinetics and Drug Distribution in Tissue to Increased Safety of Amphotericin B Colloidal Dispersion in Dogs. Antimicrob. Agents Chemother. 1992, 36, 299–307. DOI: https://doi.org/10.1128/aac.36.2.299.
- Butani, D.; Yewale, C.; Misra, A. Amphotericin B Topical Microemulsion: Formulation, Characterization and Evaluation. Colloids Surf. B Biointerfaces 2014, 116, 351–358. DOI: https://doi.org/10.1016/j.colsurfb.2014.01.014.
- Bonifácio, B. V.; Ramos, M. A. S.; Silva, P. B.; Negri, K. M. S.; Lopes, É. O.; Souza, L. P.; Vilegas, W.; Pavan, F. R.; Chorilli, M.; Bauab, T. M. Nanostructured Lipid System as a Strategy to Improve the Anti-Candida albicans Activity of Astronium Sp. Int. J. Nanomed. 2015, 10, 5081–5092. DOI: https://doi.org/10.2147/IJN.S79684.
- Bonifácio, B. V.; da Silva, P. B.; Ramos, M. A. d. S.; M.; Silveira Negri, K.; Bauab, T. M.; Chorilli, M. Nanotechnology-Based Drug Delivery Systems and Herbal Medicines: A Review. Int. J. Nanomed. 2014, 9, 1–15. DOI: https://doi.org/10.2147/IJN.S52634.
- Boonstra, J. M.; Jongedijk, E. M.; Koster, R. A.; Touw, D. J.; Alffenaar, J. W. C. Simple and Robust LC-MS/MS Analysis Method for Therapeutic Drug Monitoring of Micafungin. Bioanalysis 2018, 10, 877–886. DOI: https://doi.org/10.4155/bio-2017-0275.
- Adaway, J. E.; Keevil, B. G. Therapeutic Drug Monitoring and LC-MS/MS. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2012, 883–884, 33–49. DOI: https://doi.org/10.1016/j.jchromb.2011.09.041.
- Fiod Riccio, B. V.; Fonseca-Santos, B.; Colerato Ferrari, P.; Chorilli, M. Characteristics, Biological Properties and Analytical Methods of Trans -Resveratrol: A Review. Crit. Rev. Anal. Chem. 2019, 50, 1–20. https://doi.org/10.1080/10408347.2019.1637242.
- Hussain, A.; Alajmi, M. F.; Hussain, I.; Ali, I. Future of Ionic Liquids for Chiral Separations in High-Performance Liquid Chromatography and Capillary Electrophoresis. Crit. Rev. Anal. Chem. 2019, 49, 289–305. DOI: https://doi.org/10.1080/10408347.2018.1523706.
- Borisova-Jan, L.; Fransson, D.; Claeson, P.; Burman, R. Liquid Chromatographic Method for the Determination of Caffeoylquinic Acid Derivates in Hieracium pilosella L. Phytochem. Anal. 2017, 28, 550–557. DOI: https://doi.org/10.1002/pca.2704.
- Gaurav Kaur, V.; Kumar, A.; Malik, A. K.; Rai, P. K. SPME-HPLC: A New Approach to the Analysis of Explosives. J. Hazard. Mater. 2007, 147, 691–697. DOI: https://doi.org/10.1016/j.jhazmat.2007.05.054.
- Shipkova, M.; Svinarov, D. LC-MS/MS as a tool for TDM Services: Where Are We? Clin. Biochem. 2016, 49, 1009–1023. DOI: https://doi.org/10.1016/j.clinbiochem.2016.05.001.
- Clark, G. T.; Haynes, J. J. Utilization of DBS within Drug Discovery: A Simple 2D-LC-MS/MS System to Minimize Blood- and Paper-Based Matrix Effects from FTA Elute™ DBS. Bioanalysis 2011, 3, 1253–1270. DOI: https://doi.org/10.4155/bio.11.81.
- Cleary, J. D.; Chapman, S. W.; Deng, J.; Lobb, C. J. Amphotericin B Enzyme-Linked Immunosorbent Assay. Antimicrob. Agents Chemother. 1996, 40, 637–641. DOI: https://doi.org/10.1128/AAC.40.3.637.
- Little, J. R.; Little, K. D.; Plut, E.; Koldin, M.; Kobayashi, G. S. Induction of Amphotericin B-Specific Antibodies for Use in Immunoassays. Antimicrob. Agents Chemother. 1984, 26, 824–828. DOI: https://doi.org/10.1128/aac.26.6.824.
- Machard, S.; Theodoro, F.; Benech, H.; Grognet, J. M.; Ezan, E. A Sensitive Amphotericin B Immunoassay for Pharmacokinetic and Distribution Studies. Antimicrob. Agents Chemother. 2000, 44, 546–550. DOI: https://doi.org/10.1128/aac.44.3.546-550.2000.
- Konstantinou, G. N. Enzyme-Linked Immunosorbent Assay (ELISA). EUFIC Rev. 2017, 1592, 1–299. https://doi.org/10.1007/978-1-4939-6925-8.
- Aydin, S. A Short History, Principles, and Types of ELISA, and Our Laboratory Experience with Peptide/Protein Analyses using ELISA. Peptides 2015, 72, 4–15. DOI: https://doi.org/10.1016/j.peptides.2015.04.012.
- Sun, L.; Zhu, G.; Yan, X.; Champion, M. M.; Dovichi, N. J. Capillary Zone Electrophoresis for Analysis of Complex Proteomes Using an Electrokinetically Pumped Sheath Flow Nanospray Interface. Proteomics 2014, 14, 622–628. DOI: https://doi.org/10.1002/pmic.201300295.
- Yadav, L. D. S. Introduction to Spectroscopy (Spectrometry). Org. Spectrosc. 2005, 1–6.
- Storey, P. Introduction to Magnetic Resonance Imaging and Spectroscopy. Dairy Ind. Int. 2005, 70, 28.
- Granich, G. G.; Kobayashi, G. S.; Krogstad, D. J. Sensitive High-Pressure Liquid Chromatographic Assay for Amphotericin B which Incorporates an Internal Standard. Antimicrob. Agents Chemother. 1986, 29, 584–588. DOI: https://doi.org/10.1128/aac.29.4.584.
- Wang, L. H.; Smith, P. C.; Anderson, K. L.; Fielding, R. M. High-Performance Liquid Chromatographic Analysis of Amphotericin B in Plasma, Blood, Urine and Tissues for Pharmacokinetic and Tissue Distribution Studies. J. Chromatogr. B Biomed. Sci. Appl. 1992, 579, 259–268. DOI: https://doi.org/10.1016/0378-4347(92)80390-C.
- Lopez-Galera, R.; Pou-Clave, L.; Pascual-Mostaza, C. Determination of Amphotericin B in Human Serum by Liquid Chromatography. J. Chromatogr. B Biomed. Sci. Appl. 1995, 674, 298–300. DOI: https://doi.org/10.1016/0378-4347(95)00322-3.
- Echevarría, I.; Barturen, C.; Renedo, M. J.; Dios-Viéitez, M. C. High-Performance Liquid Chromatographic Determination of Amphotericin B in Plasma and Tissue. Application to Pharmacokinetic and Tissue Distribution Studies in Rats. J. Chromatogr. A 1998, 819, 171–176. DOI: https://doi.org/10.1016/S0021-9673(98)00425-7.
- Lopez, R.; Pou, L.; Andres, I.; Monforte, V.; Roman, A.; Pascual, C. Amphotericin B Determination in Respiratory Secretions by Reversed-Phase Liquid Chromatography. J. Chromatogr. A 1998, 812, 135–139. DOI: https://doi.org/10.1016/S0021-9673(98)00205-2.
- Eldem, T.; Arican, C. Determination of Amphotericin B in Human Plasma Using Solid-Phase Extraction and High-Performance Liquid Chromatography. J. Pharm. Biomed. Anal. 2001, 39, 791–795. https://doi.org/10.1016/j.jpba.2005.04.025.
- Bekersky, I.; Fielding, R. M.; Dressler, D. E.; Lee, J. W.; Buell, D. N.; Walsh, T. J. Pharmacokinetics, Excretion, and Mass Balance of Liposomal Amphotericin B (AmBisome) and Amphotericin B Deoxycholate in Humans. Antimicrob. Agents Chemother. 2002, 46, 828–833. DOI: https://doi.org/10.1128/AAC.46.3.828-833.2002.
- Espada, R.; Josa, L. M.; Valdespina, S.; Dea, M. A.; Ballesteros, M. P.; Alunda, J. M.; Torrado, J. Thiacarbocyanine as Ligand in Dye-Affinity Chromatography. Biomed. Chromatogr. 2008, 22, 402–288. . DOI: https://doi.org/10.1002/bmc.947.
- Italia, J. L.; Singh, D.; Ravi Kumar, M. N. V. High-Performance Liquid Chromatographic Analysis of Amphotericin B in Rat Plasma Using Alpha-Naphthol as an Internal Standard. Anal. Chim. Acta. 2009, 634, 110–114. DOI: https://doi.org/10.1016/j.aca.2008.12.006.
- Xu; Julin, G.; Yuanjie, Z.; Hai, W.; Qiushi, R.; Jianghan, C. Efficacy of Intravenous Amphotericin B-Polybutylcyanoacrylate Nanoparticles against Cryptococcal meningitis in Mice. Int. J. Nanomed. 2011, 6, 905–913. https://doi.org/10.2147/ijn.s17503.
- Barco, S.; Zunino, A.; D’Avolio, A.; Barbagallo, L.; Maffia, A.; Tripodi, G.; Castagnola, E.; Cangemi, G. A Rapid and Robust UHPLC-DAD Method for the Quantification of Amphotericin B in Human Plasma. J. Pharm. Biomed. Anal. 2017, 138, 142–145. DOI: https://doi.org/10.1016/j.jpba.2017.01.048.
- Schiave, L. A.; Nascimento, E.; Gaspar, G. G.; Vilar, F. C.; Martinez, E. Z.; Gaitani, C. M. d.; Martinez, R. Minimum Concentration of Amphotericin B in Serum according to the Formulation, Dose, and Daily or Prolonged Intermittent Therapeutic Regimen. Rev. Soc. Bras. Med. Trop. 2020, 53, 1–7. DOI: https://doi.org/10.1590/0037-8682-0463-2018.
- Vogeser, M.; Parhofer, K. G. Liquid Chromatography Tandem-Mass Spectrometry (LC-MS/MS)-Technique and Applications in Endocrinology. Exp. Clin. Endocrinol. Diabetes 2007, 115, 559–570. DOI: https://doi.org/10.1055/s-2007-981458.
- Lee, J. W.; Petersen, M. E.; Lin, P.; Dressler, D.; Bekersky, I. Quantitation of Free and Total Amphotericin B in Human Biologic Matrices by a Liquid Chromatography Tandem Mass Spectrometric Method. Ther. Drug Monit. 2001, 23, 268–276. DOI: https://doi.org/10.1097/00007691-200106000-00015.
- Xiong, X.; Zhai, S.; Liu, F. Determination of Amphotericin B in Human Cerebrospinal Fluid by LC-MS-MS. Chromatographia 2009, 70, 329–332. DOI: https://doi.org/10.1365/s10337-009-1112-1.
- Deshpande, N. M.; Gangrade, M. G.; Kekare, M. B.; Vaidya, V. V. Determination of Free and Liposomal Amphotericin B in Human Plasma by Liquid Chromatography-Mass Spectroscopy with Solid Phase Extraction and Protein Precipitation Techniques. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2010, 878, 315–326. DOI: https://doi.org/10.1016/j.jchromb.2009.11.036.
- Qin, W.; Tao, H.; Chen, Y.; Chen, Z.; Wu, N. Sensitive, Accurate and Simple Liquid Chromatography-Tandem Mass Spectrometric Method for the Quantitation of Amphotericin B in Human or Minipig Plasma. J. Chromatogr. Sci. 2012, 50, 636–643. DOI: https://doi.org/10.1093/chromsci/bms049.
- Fang, M.; Lü, T. M.; Ma, A.; De; Wang, L.; Li, G. L.; Qiu, A. Z.; Pan, Z. Y.; Wang, Y. Y.; Liu, X. J. Comparative Pharmacokinetics of Continuous and Conventional Intrathecal Amphotericin B in Rabbits. Antimicrob. Agents Chemother. 2012, 56, 5253–5257. DOI: https://doi.org/10.1128/AAC.00304-12.
- Su, C.; Yang, H.; Sun, H.; Fawcett, J. P.; Sun, D.; Gu, J. Bioanalysis of Free and Liposomal Amphotericin B in Rat Plasma Using Solid Phase Extraction and Protein Precipitation Followed by LC-MS/MS. J. Pharm. Biomed. Anal. 2018, 158, 288–293. DOI: https://doi.org/10.1016/j.jpba.2018.06.014.
- Botsoglou, N. A.; Fletouris, D. J.; Papageorgiou, G. E.; Florou-Paner, P.; Mantis, A. J. Rapid Determination of Amphotericin B in Serum and Urine by Third-Order Derivative Spectrophotometry. J. Pharm. Sci. 1996, 85, 402–406. DOI: https://doi.org/10.1021/js950398a.
- Monteil, C. G.; Kergueris, M. F.; Iooss, P.; Thomas, L.; Larousse, C. Quantitation of Amphotericin B in Plasma by Second-Derivative Spectrophotometry. J. Pharm. Biomed. Anal. 1998, 17, 481–485. DOI: https://doi.org/10.1016/S0731-7085(97)00215-X.
- Millership, J. S.; McCaffrey, F.; Tierney, D. A Novel Application of Ratio Spectra Derivative Spectroscopy for the Determination of Amphotericin in Highly Icteric Plasma. J. Pharm. Biomed. Anal. 2008, 48, 408–413. DOI: https://doi.org/10.1016/j.jpba.2007.12.043.
- Cleary, J. D.; Chapman, S. W.; Hardin, T. C.; Rinaldi, M. G.; Spencer, J. L.; Deng, J.; Pennick, G. J.; Lobb, C. J. Amphotericin B Enzyme-Linked Immunoassay for Clinical Use: Comparison with Bioassay and HPLC. Ann. Pharmacother. 1997, 31, 39–44. DOI: https://doi.org/10.1177/106002809703100105.
- Šalplachta, J.; Horká, M.; Šlais, K. Capillary Electrophoresis with Preparative Isoelectric Focusing Preconcentration for Sensitive Determination of Amphotericin B in human blood serum. Anal. Chim. Acta 2019, 1053, 162–168. DOI: https://doi.org/10.1016/j.aca.2018.12.010.
- Zavaleta, C.; De La Zerda, A.; Liu, L.; Keren, S.; Cheng, Z.; Schipper, M.; Chen, X.; Dai, H.; Gambhir, S. S. Noninvasive Raman Spectroscopy in Living Mice for Evaluation of Tumor Targeting with Carbon Nanotubes. Nano Lett. 2008, 8, 2800–2805. . DOI: https://doi.org/10.1021/nl801362a.
- Ridente, Y.; Aubard, J.; Bolard, J. Absence in Amphotericin B-Spiked Human Plasma of the Free Monomeric Drug, as Detected by SERS. FEBS Lett. 1999, 446, 283–286. DOI: https://doi.org/10.1016/S0014-5793(99)00238-0.
- Miyaoka, R.; Hosokawa, M.; Ando, M.; Mori, T.; Hamaguchi, H. O.; Takeyama, H. In Situ Detection of Antibiotic Amphotericin B Produced in Streptomyces nodosus Using Raman Microspectroscopy. Mar. Drugs. 2014, 12, 2827–2839. DOI: https://doi.org/10.3390/md12052827.
- Clemons, K. V.; Sobel, R. A.; Williams, P. L.; Stevens, D. A. Comparative Toxicities and Pharmacokinetics of Intrathecal Lipid (Amphotericin B Colloidal Dispersion) and Conventional Deoxycholate Formulations of Amphotericin B in Rabbits. Antimicrob. Agents Chemother. 2001, 45, 612–615. DOI: https://doi.org/10.1128/AAC.45.2.612-615.2001.
- Kuklenyik, P.; Baker, S. E.; Bishop, A. M.; Morales-A, P.; Calafat, A. M. On-Line Solid Phase Extraction-High Performance Liquid Chromatography-Isotope Dilution-Tandem Mass Spectrometry Approach to Quantify N,N-Diethyl-m-Toluamide and Oxidative Metabolites in Urine. Anal. Chim. Acta 2013, 787, 267–273. DOI: https://doi.org/10.1016/j.aca.2013.05.055.
- Hu, Q.; Noll, R. J.; Li, H.; Makarov, A.; Hardman, M.; Cooks, R. G. The Orbitrap: A New Mass Spectrometer. J. Mass Spectrom. 2005, 40, 430–443. DOI: https://doi.org/10.1002/jms.856.
- Qu, L.; Qian, J.; Ma, P.; Yin, Z. Utilizing Online-Dual-SPE-LC with HRMS for the Simultaneous Quantification of Amphotericin B, Fluconazole, and Fluorocytosine in Human Plasma and Cerebrospinal Fluid. Talanta 2017, 165, 449–457. DOI: https://doi.org/10.1016/j.talanta.2016.12.052.
- Chandran, S.; Singh, R. S. P. Comparison of Various International Guidelines for Analytical Method Validation. Pharmazie 2007, 62, 4–14. https://doi.org/10.1691/ph.2007.1.5064.
- Margosis, M.; Aszalos, A. Quantitation of Amphotericins by Reverse-Phase High-Performance Liquid Chromatography. J. Pharm. Sci. 1984, 73, 835–838. DOI: https://doi.org/10.1002/jps.2600730635.
- Wilkinson, J. M.; McDonald, C.; Parkin, J. E.; Sunderland, V. B. A High-Performance Liquid-Chromatographic Assay for Amphotericin B in a Hydrophilic Colloidal Paste Base. J. Pharm. Biomed. Anal. 1998, 17, 751–755. DOI: https://doi.org/10.1016/S0731-7085(97)00250-1.
- Eldem, T.; Arican-Cellat, N. High-Performance Liquid Chromatographic Determination of Amphotericin B in a Liposomal Pharmaceutical Product and Validation of the Assay. J. Chromatogr. Sci. 2000, 38, 338–344. DOI: https://doi.org/10.1093/chromsci/38.8.338.
- Manosroi, A.; Kongkaneramit, L.; Manosroi, J. Characterization of Amphotericin B Liposome Formulations. Drug Dev. Ind. Pharm. 2004, 30, 535–543. DOI: https://doi.org/10.1081/ddc-120037484.
- Groeschke, J.; Solassol, I.; Bressolle, F.; Pinguet, F. Stability of Amphotericin B and Nystatin in Antifungal Mouthrinses Containing Sodium Hydrogen Carbonate. J. Pharm. Biomed. Anal. 2006, 42, 362–366. DOI: https://doi.org/10.1016/j.jpba.2006.04.011.
- Morand, K.; Bartoletti, A. C.; Bochot, A.; Barratt, G.; Brandely, M. L.; Chast, F. Liposomal Amphotericin B Eye Drops to Treat Fungal Keratitis: Physico-Chemical and Formulation Stability. Int. J. Pharm. 2007, 344, 150–153. DOI: https://doi.org/10.1016/j.ijpharm.2007.04.028.
- Chang, Y.; Wang, Y. H.; Hu, C. Q. Simultaneous Determination of Purity and Potency of Amphotericin B by HPLC. J. Antibiot., 2011, 64, 735–739. DOI: https://doi.org/10.1038/ja.2011.83.
- Rodrigues, C. D.; Khalil, N. M.; Mainardes, R. M. Determination of Amphotericin B in PLA-PEG Blend Nanoparticles by HPLC-PDA. Braz. J. Pharm. Sci. 2014, 50, 859–868. DOI: https://doi.org/10.1590/S1984-82502014000400021.
- Pfeifer, C.; Fassauer, G.; Gerecke, H.; Jira, T.; Remane, Y.; Frontini, R.; Byrne, J.; Reinhardt, R. Purity Determination of Amphotericin B, Colistin Sulfate and Tobramycin Sulfate in a Hydrophilic Suspension by HPLC. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2015, 990, 7–14. DOI: https://doi.org/10.1016/j.jchromb.2015.02.043.
- Tan, T. R. M.; Hoi, K. M.; Zhang, P.; Ng, S. K. Characterization of a Polyethylene Glycol-Amphotericin B Conjugate Loaded with Free AMB for Improved Antifungal Efficacy. PLoS One 2016, 11, e0152112. DOI: https://doi.org/10.1371/journal.pone.0152112.
- Tadini, M. C.; de Freitas Pinheiro, A. M.; Carrão, D. B.; Aguillera Forte, A. L. S.; Nikolaou, S.; de Oliveira, A. R. M.; Berretta, A. A.; Marquele-Oliveira, F. Method Validation and Nanoparticle Characterization Assays for an Innovative Amphothericin B Formulation to Reach Increased Stability and Safety in Infectious Diseases. J. Pharm. Biomed. Anal. 2017, 145, 576–585. DOI: https://doi.org/10.1016/j.jpba.2017.06.034.
- Kumar, P.; Shivam, P.; Mandal, S.; Prasanna, P.; Kumar, S.; Prasad, S. R.; Kumar, A.; Das, P.; Ali, V.; Singh, S. K.; et al. Synthesis, Characterization, and Mechanistic Studies of a Gold Nanoparticle-Amphotericin B Covalent Conjugate with Enhanced Antileishmanial Efficacy and Reduced Cytotoxicity. Int. J. Nanomed. 2019, 14, 6073–6101. DOI: https://doi.org/10.2147/IJN.S196421.
- Cleary, J. D.; Rogers, P. D.; Chapman, S. W. Variability in Polyene Content and Cellular Toxicity among Deoxycholate Amphotericin B Formulations. Pharmacotherapy 2003, 23, 572–578. DOI: https://doi.org/10.1592/phco.23.5.572.32209.
- Cleary, J. D.; Chapman, S. W.; Swiatlo, E.; Kramer, R. High Purity Amphotericin B. J. Antimicrob. Chemother. 2007, 60, 1331–1340. DOI: https://doi.org/10.1093/jac/dkm322.
- Larabi, M.; Gulik, A.; Dedieu, J. P.; Legrand, P.; Barratt, G.; Cheron, M. New Lipid Formulation of Amphotericin B: Spectral and Microscopic Analysis. Biochim. Biophys. Acta 2004, 1664, 172–181. DOI: https://doi.org/10.1016/j.bbamem.2004.05.003.
- Bianco, M. A.; Gallarate, M.; Trotta, M.; Battaglia, L. Amphotericin B Loaded SLN Prepared with the Coacervation Technique. J. Drug Deliv. Sci. Technol. 2010, 20, 187–191. DOI: https://doi.org/10.1016/S1773-2247(10)50028-5.
- Kumar, V.; Adamson, D. H.; Prud'homme, R. K. Fluorescent Polymeric Nanoparticles: Aggregation and Phase Behavior of Pyrene and Amphotericin B Molecules in Nanoparticle Cores. Small 2010, 6, 2907–2914. DOI: https://doi.org/10.1002/smll.201001199.
- Horká, M.; Slais, K.; Karásek, P.; Ruzicka, F.; Salplachta, J.; Sestak, J.; Kahle, V.; Roth, M. Capillary Electrophoresis in a Fused-Silica Capillary with Surface Roughness Gradient. J. Sep. Sci. 2014, 1–23. https://doi.org/10.1002/jssc.201400030.This.
- Jansook, P.; Fülöp, Z.; Ritthidej, G. C. Amphotericin B Loaded Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carrier (NLCs): Physicochemical and Solid-Solution State Characterizations. Drug Dev. Ind. Pharm. 2019, 45, 560–567. DOI: https://doi.org/10.1080/03639045.2019.1569023.